Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 3 Recruiting 1

Sponsor Class

OTHER 22 INDUSTRY 17 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Adenocarcinoma 1

Interventions

Specimen Handling 39 Magnetic Resonance Spectroscopy 30 Carboplatin 14 Biopsy 14 Radiation 13 Cyclophosphamide 13 Radiotherapy 11 daratumumab 10 Vincristine 10 Dexamethasone 10 Surgical Procedures, Operative 9 Etoposide 9 Lenalidomide 8 X-Rays 7 Observation 7 Leucovorin 7 Irinotecan 7 Doxorubicin 7 Cisplatin 7 durvalumab 6 dexamethasone acetate 6 dexamethasone 21-phosphate 6 auricularum 6 Watchful Waiting 6 Radiosurgery 6 Docetaxel 6 Calcium Dobesilate 6 pembrolizumab 5 Stem Cell Transplantation 5 Standard of Care 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NETWORK × darolutamide × Clear all

NCT06592924 2026-04-14

TRIPLE-SWITCH

Canadian Cancer Trials Group

Phase 3 Recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡